Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder (MIP)

This study has been completed.
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Aaron Hogue, The National Center on Addiction and Substance Abuse at Columbia University Identifier:
First received: June 7, 2011
Last updated: August 3, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)